PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

27 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Lay all publications on this page into basket
1.
Liang, N.* et al.: Peripheral metabolism informs on future cognitive decline and development of Alzheimer’s disease in population at risk. Alzheimers Dement. 20, 1:e089802 (2025)
2.
Wagemann, O.* et al.: Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease. Alzheimers Dement. 21:e70040 (2025)
3.
Arnold, M.: Integrating multi-omics data for target and biomarker discovery. In:. 2024.:e086331 (Alzheimers Dement. ; 20 Suppl 1)
4.
Batra, R.* et al.: Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy. Alzheimers Dement., DOI: 10.1002/alz.14249 (2024)
5.
Batra, R.* et al.: Central and Peripheral Biochemical Changes in Alzheimer’sDisease: Insights from the Alzheimer Disease MetabolomicsConsortium. In:. 2024.:e092421 (Alzheimers Dement. ; 20 Suppl 2)
6.
Fish, L.A.* et al.: A cognitive resilience gene expression signature in excitatory intratelencephalic cortical neurons. In:. 2024.:e095063 (Alzheimers Dement. ; 20 Suppl 8)
7.
Hüper, L.* et al.: Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers. Alzheimers Dement., DOI: 10.1002/alz.13863 (2024)
8.
MahmoudianDehkordi, S.* et al.: Metabolomics Analysis of the MIND Study Informs about Metabolic Benefit and Heterogeneity among Individuals‐ A Precision Medicine Approach for Diet Interventions. In:. 2024.:e089899 (Alzheimers Dement. ; 20 Suppl 2)
9.
Pandey, R.S.* et al.: Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.13851 (2024)
10.
Schweickart, A.* et al.: A Modified Mediterranean Ketogenic Diet reverses signaturesand mitigates modifiable risk factors of Alzheimer’s disease. In:. 2024.:e089878 (Alzheimers Dement. ; 20 Suppl 7)
11.
Telpoukhovskaia, M.A.* et al.: New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop. Alzheimers Dement. 10:e12458 (2024)
12.
Arnold, M. et al.: Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease. Poster: Basic Science and Pathogenesis – Part 1 (2023)
13.
Batra, R.* et al.: The landscape of metabolic brain alterations in Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12714 (2022)
14.
Labus, J.S.* et al.: Interactions between brain and bile acid ratio profiles predict baseline cognitive status. Alzheimers Dement. 18:e067272 (2022)
15.
Oeckl, P.* et al.: Relationship of serum beta-synuclein with blood biomarkers and brain atrophy. Alzheimers Dement. 19, 1358-1371 (2022)
16.
van Duijn, C.M.* et al.: Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression. Alzheimers Dement. 18:e067261 (2022)
17.
Wang, T.* et al.: APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimers Dement. 18, 2151-2166 (2022)
18.
Wörheide, M. ; Krumsiek, J.* ; Kastenmüller, G. ; Kaddurah-Daouk, R.F.* & Arnold, M.: A proof of concept study towards multi-omics-based computational drug repositioning in Alzheimer's disease. Alzheimers Dement. 17, 3:e056673 (2022)
19.
Baloni, P.* et al.: Investigating the importance of acylcarnitines in Alzheimer's disease. Alzheimers Dement. 17:e056647 (2021)
20.
Horgusluoglu, E.* et al.: Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12468 (2021)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮